Search research articles
Contact Us
Filters
Showing results (11-20 of 42) with videos related to
Page
of 5
Sort By:
Journal of Telemedicine and Telecare
|
October 18, 2021
Patient satisfaction with telehealth consultations in medical oncology clinics: A cross-sectional study at a metropolitan centre during the COVID-19 pandemic
Andrew O Parsonson, Peter Grimison, Michael Boyer, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
May 17, 2017
Neurophysiological and clinical outcomes in chemotherapy-induced neuropathy in cancer
Tejaswi Kandula, Michelle A Farrar, Matthew C Kiernan, et al.
Therapeutic Advances in Medical Oncology
|
December 18, 2024
Evolocumab in metastatic castration-resistant prostate cancer: study protocol for a single-arm, phase II trial, and initial experience with use of a validated lipid biomarker to direct therapy
Rhiannon Mellor, Luke Ardolino, Tahlia Scheinberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 16, 2018
Rapid Modulation of PSMA Expression by Androgen Deprivation: Serial <sup>68</sup>Ga-PSMA-11 PET in Men with Hormone-Sensitive and Castrate-Resistant Prostate Cancer Commencing Androgen Blockade
Louise Emmett, Charlotte Yin, Megan Crumbaker, et al.
Cancer Chemotherapy and Pharmacology
|
January 26, 2021
A phase 1 trial of 4-(N-(S-penicillaminylacetyl)amino)-phenylarsonous acid (PENAO) in patients with advanced solid tumours
Sunit Sarkar, Ben Tran, Lisa Horvath, et al.
JCO Clinical Cancer Informatics
|
July 25, 2023
Multi-Omic Integration of Blood-Based Tumor-Associated Genomic and Lipidomic Profiles Using Machine Learning Models in Metastatic Prostate Cancer
Shikai Fang, Shandian Zhe, Hui-Ming Lin, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
June 8, 2017
Optimal clinical assessment strategies for chemotherapy-induced peripheral neuropathy (CIPN): a systematic review and Delphi survey
J Matt McCrary, David Goldstein, Frances Boyle, et al.
Clinical Genitourinary Cancer
|
November 15, 2018
Results of a Prospective Phase 2 Pilot Trial of <sup>177</sup>Lu-PSMA-617 Therapy for Metastatic Castration-Resistant Prostate Cancer Including Imaging Predictors of Treatment Response and Patterns of Progression
Louise Emmett, Megan Crumbaker, Bao Ho, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 10, 2010
Report of a multicenter phase II trial testing a combination of biweekly bevacizumab and daily erlotinib in patients with unresectable biliary cancer: a phase II Consortium study
Sam J Lubner, Michelle R Mahoney, Jill L Kolesar, et al.
European Urology
|
February 6, 2018
Expression of Androgen Receptor Splice Variant 7 or 9 in Whole Blood Does Not Predict Response to Androgen-Axis-targeting Agents in Metastatic Castration-resistant Prostate Cancer
Sarah Q To, Edmond M Kwan, Heidi C Fettke, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 42) with videos related to
Sort By:
Page
of 5
Journal of Telemedicine and Telecare
|
October 18, 2021
Patient satisfaction with telehealth consultations in medical oncology clinics: A cross-sectional study at a metropolitan centre during the COVID-19 pandemic
Andrew O Parsonson, Peter Grimison, Michael Boyer, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
May 17, 2017
Neurophysiological and clinical outcomes in chemotherapy-induced neuropathy in cancer
Tejaswi Kandula, Michelle A Farrar, Matthew C Kiernan, et al.
Therapeutic Advances in Medical Oncology
|
December 18, 2024
Evolocumab in metastatic castration-resistant prostate cancer: study protocol for a single-arm, phase II trial, and initial experience with use of a validated lipid biomarker to direct therapy
Rhiannon Mellor, Luke Ardolino, Tahlia Scheinberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 16, 2018
Rapid Modulation of PSMA Expression by Androgen Deprivation: Serial <sup>68</sup>Ga-PSMA-11 PET in Men with Hormone-Sensitive and Castrate-Resistant Prostate Cancer Commencing Androgen Blockade
Louise Emmett, Charlotte Yin, Megan Crumbaker, et al.
Cancer Chemotherapy and Pharmacology
|
January 26, 2021
A phase 1 trial of 4-(N-(S-penicillaminylacetyl)amino)-phenylarsonous acid (PENAO) in patients with advanced solid tumours
Sunit Sarkar, Ben Tran, Lisa Horvath, et al.
JCO Clinical Cancer Informatics
|
July 25, 2023
Multi-Omic Integration of Blood-Based Tumor-Associated Genomic and Lipidomic Profiles Using Machine Learning Models in Metastatic Prostate Cancer
Shikai Fang, Shandian Zhe, Hui-Ming Lin, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
June 8, 2017
Optimal clinical assessment strategies for chemotherapy-induced peripheral neuropathy (CIPN): a systematic review and Delphi survey
J Matt McCrary, David Goldstein, Frances Boyle, et al.
Clinical Genitourinary Cancer
|
November 15, 2018
Results of a Prospective Phase 2 Pilot Trial of <sup>177</sup>Lu-PSMA-617 Therapy for Metastatic Castration-Resistant Prostate Cancer Including Imaging Predictors of Treatment Response and Patterns of Progression
Louise Emmett, Megan Crumbaker, Bao Ho, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 10, 2010
Report of a multicenter phase II trial testing a combination of biweekly bevacizumab and daily erlotinib in patients with unresectable biliary cancer: a phase II Consortium study
Sam J Lubner, Michelle R Mahoney, Jill L Kolesar, et al.
European Urology
|
February 6, 2018
Expression of Androgen Receptor Splice Variant 7 or 9 in Whole Blood Does Not Predict Response to Androgen-Axis-targeting Agents in Metastatic Castration-resistant Prostate Cancer
Sarah Q To, Edmond M Kwan, Heidi C Fettke, et al.
Page
of 5